CardioComm Press Release - November 29, 2006

CardioComm Solutions Inc. Announces New Director

VICTORIA, B.C., November 29, 2006 – CardioComm Solutions Inc. (TSX-V:CCG) ("CardioComm", the “Company”), is pleased to announce that Mr. Etienne Grima MSc., CHE has joined the Board of Directors effective immediately.

Mr. Grima brings almost 20 years of wide ranging experience to the Board such as basic and clinical administration, business development and a dedication to corporate governance. Mr. Grima is a co-founder of the Canadian Heart Research Centre (“CHRC”) where he acts as COO and CFO. Prior to co-founding the CHRC, Mr. Grima managed the St. Michael's Hospital Health Sciences Research Centre which is comprised of 120 research members and over 100 research staff. During his tenure, he developed a detailed understanding and methodology of the successful performance of clinical research within a hospital environment and became a member and Accredited Health Science Executive of the Canadian College of Health Service Executives.

Mr. Grima earned an undergraduate degree of the University of Toronto . He completed his graduate studies in 1986 with a Masters degree from the Faculty of Medicine, Department of Physiology, Centre for Research in Neurodegenerative Diseases.

Brad Harlow, Chairman of the Board, remarked, “We are very pleased and encouraged to welcome Mr Grima to the Board. His guidance will be invaluable as someone who has extensive experience in budgetary development, clinical research administration and as someone who is dedicated to research and education in the treatment and prevention of cardiovascular disease.”

As a co-founder of the CHRC which is a preferred provider for conducting clinical research in both Canada and the United States , Mr. Grima will bring a unique insight to the Company as it focuses to develop a series of commercially designed software programs to the marketplace such as the recently announced co-development deal with MD Primer Inc. Over the past ten years, the CHRC has not only developed exceptional relationships with the medical departments of major teaching and community hospitals but has also developed significant lines of communication with the legal council and research administrative offices representing clinical researchers across North America.

About CardioComm Solutions Inc.

CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. The Company's products are sold worldwide through a combination of its external distribution network and its North American based sales team. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer. CardioComm is the first company to provide a real-time means of viewing ECGs over a network (LAN, WAN or Internet). This tool enables ECGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global ECG Management System (GEMS™) and GlobalCardio™. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has earned the latest ISO 13485 certification.

On behalf of the Board of Directors of CardioComm Solutions Inc.

“Stephen Martin”

Stephen R. Martin, President & CEO

For investor information, please contact:

Stephen Martin
1-877-744-1122